BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16537906)

  • 1. Transcriptional link between blood and bone: the stem cell leukemia gene and its +19 stem cell enhancer are active in bone cells.
    Pimanda JE; Silberstein L; Dominici M; Dekel B; Bowen M; Oldham S; Kallianpur A; Brandt SJ; Tannahill D; Göttgens B; Green AR
    Mol Cell Biol; 2006 Apr; 26(7):2615-25. PubMed ID: 16537906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.
    Göttgens B; Broccardo C; Sanchez MJ; Deveaux S; Murphy G; Göthert JR; Kotsopoulou E; Kinston S; Delaney L; Piltz S; Barton LM; Knezevic K; Erber WN; Begley CG; Frampton J; Green AR
    Mol Cell Biol; 2004 Mar; 24(5):1870-83. PubMed ID: 14966269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors.
    Göttgens B; Nastos A; Kinston S; Piltz S; Delabesse EC; Stanley M; Sanchez MJ; Ciau-Uitz A; Patient R; Green AR
    EMBO J; 2002 Jun; 21(12):3039-50. PubMed ID: 12065417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SCL +40 enhancer targets the midbrain together with primitive and definitive hematopoiesis and is regulated by SCL and GATA proteins.
    Ogilvy S; Ferreira R; Piltz SG; Bowen JM; Göttgens B; Green AR
    Mol Cell Biol; 2007 Oct; 27(20):7206-19. PubMed ID: 17709394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective rescue of early haematopoietic progenitors in Scl(-/-) mice by expressing Scl under the control of a stem cell enhancer.
    Sánchez MJ; Bockamp EO; Miller J; Gambardella L; Green AR
    Development; 2001 Dec; 128(23):4815-27. PubMed ID: 11731461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development.
    Pimanda JE; Ottersbach K; Knezevic K; Kinston S; Chan WY; Wilson NK; Landry JR; Wood AD; Kolb-Kokocinski A; Green AR; Tannahill D; Lacaud G; Kouskoff V; Göttgens B
    Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17692-7. PubMed ID: 17962413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SCL 3' enhancer responds to Hedgehog signaling during hemangioblast specification.
    Hochman E; Kinston S; Harmelin A; Göttgens B; Izraeli S
    Exp Hematol; 2006 Dec; 34(12):1643-50. PubMed ID: 17157160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors.
    Sánchez M; Göttgens B; Sinclair AM; Stanley M; Begley CG; Hunter S; Green AR
    Development; 1999 Sep; 126(17):3891-904. PubMed ID: 10433917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.
    Ferreira R; Spensberger D; Silber Y; Dimond A; Li J; Green AR; Göttgens B
    Mol Cell Biol; 2013 Mar; 33(6):1254-66. PubMed ID: 23319051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo.
    Delabesse E; Ogilvy S; Chapman MA; Piltz SG; Gottgens B; Green AR
    Mol Cell Biol; 2005 Jun; 25(12):5215-25. PubMed ID: 15923636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic analysis of the stem cell leukemia +19 stem cell enhancer in adult and embryonic hematopoietic and endothelial cells.
    Silberstein L; Sánchez MJ; Socolovsky M; Liu Y; Hoffman G; Kinston S; Piltz S; Bowen M; Gambardella L; Green AR; Göttgens B
    Stem Cells; 2005 Oct; 23(9):1378-88. PubMed ID: 16051983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype.
    Chan WY; Follows GA; Lacaud G; Pimanda JE; Landry JR; Kinston S; Knezevic K; Piltz S; Donaldson IJ; Gambardella L; Sablitzky F; Green AR; Kouskoff V; Göttgens B
    Blood; 2007 Mar; 109(5):1908-16. PubMed ID: 17053063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer.
    Nottingham WT; Jarratt A; Burgess M; Speck CL; Cheng JF; Prabhakar S; Rubin EM; Li PS; Sloane-Stanley J; Kong-A-San J; de Bruijn MF
    Blood; 2007 Dec; 110(13):4188-97. PubMed ID: 17823307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
    Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
    Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
    Cooper S; Guo H; Friedman AD
    PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lineage-restricted regulation of the murine SCL/TAL-1 promoter.
    Bockamp EO; McLaughlin F; Murrell AM; Göttgens B; Robb L; Begley CG; Green AR
    Blood; 1995 Aug; 86(4):1502-14. PubMed ID: 7632958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant mast-cell differentiation in mice lacking the stem-cell leukemia gene.
    Salmon JM; Slater NJ; Hall MA; McCormack MP; Nutt SL; Jane SM; Curtis DJ
    Blood; 2007 Nov; 110(10):3573-81. PubMed ID: 17644741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development.
    Kappel A; Schlaeger TM; Flamme I; Orkin SH; Risau W; Breier G
    Blood; 2000 Nov; 96(9):3078-85. PubMed ID: 11049987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis.
    Kallianpur AR; Jordan JE; Brandt SJ
    Blood; 1994 Mar; 83(5):1200-8. PubMed ID: 8118024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCL/Tal-1 is essential for hematopoietic commitment of the hemangioblast but not for its development.
    D'Souza SL; Elefanty AG; Keller G
    Blood; 2005 May; 105(10):3862-70. PubMed ID: 15677567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.